The Benefits of Designing CDMO Facilities in Anticipation of Annex 1
Three reasons Grand River Aseptic Manufacturing (GRAM) is in a positive regulatory position. In celebration of August 25, 2023, when…
Grand River Aseptic Manufacturing awarded 2023 Winner for the Best and Brightest Companies to Work For® in the Nation and in West Michigan
Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable pharmaceutical contract manufacturer, is named a 2023 Winner for the Best…
Grand River Aseptic Manufacturing Diverts 30,357 lbs. of PPE from Landfills
On April 21st, 2023, Grand River Aseptic Manufacturing (GRAM) held a sustainability celebration and a local park cleanup ahead of…
Grand River Aseptic Manufacturing Receives Zero Observations from FDA Inspection, Aiding in the Supply of Bavarian Nordic’s JYNNEOS®
FOR IMMEDIATE RELEASE GRAND RAPIDS, Mich. (March 17, 2023) – Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable pharmaceutical contract…
How to address the complexity of products being studied for multiple indications in multiple drug delivery options
More and more frequently, injectable drug products are undergoing clinical trials for multiple indications while also being developed for multiple…
Honoring our team’s contributions to the local community
2022 GRAM Giving We would like to honor the GRAM team for giving their time and financial contributions to help…
West, Kymanox, & Grand River Aseptic Manufacturing tackle hot topics within the pharma and biotech industry
Webinar: Planning for Multiple Product Indications and Presentations Your company has developed a biological product. Often the “norm” is drugs…
Grand River Aseptic Manufacturing to Fill and Finish Smallpox/Monkeypox Vaccines and Accelerate Domestic Supply
Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has entered into an…
Grand River Aseptic Manufacturing Completes Phase II Expansion with Installation of Two New Sterile Filling Lines
Grand River Aseptic Manufacturing (“GRAM”), a prominent parenteral drug product contract development and manufacturing organization (CDMO), has completed Phase II…